Takara Bio Grants Transgenomic License for LA-PCR Technology.Tokyo, Japan, May 7, 2007 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Takara Bio Inc. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4974) today announced that it has granted Transgenomic, Inc. a worldwide non-exclusive license to make, use and sell LA-PCR related products. Including Transgenomic, the company has nineteen (19) licensees of its LA-PCR technology worldwide. Financial terms of the license were not disclosed. LA-PCR Technology, invented by Dr. Wayne M. Barnes, is a breakthrough in PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) (Polymerase Chain Reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is ) technology that expands its capability and heightens its application potential considerably. LA-PCR technology overcomes the disadvantages and defects of conventional PCR by enabling high-yield amplification of long and complex DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. fragments from genomic DNA genomic DNA n. The full complement of DNA contained in the genome of a cell or organism. . More importantly for the molecular researcher, DNA molecules produced with LA-PCR Technology have significantly fewer mutations than those made using conventional PCR. The company entered into a Patent Assignment Agreement with Dr. Barnes in April 1996 and acquired all of Dr. Barnes' right, title and interest in and to the patents relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc LA technology. The company continues to promote licensing of this technology as well as sales of its own products worldwide. About Takara Bio Inc. Takara Bio Inc. is committed to preventing disease and improving the quality of life of people around the world through the use of biotechnology. Takara Bio is divided into three separate divisions; DNAtech, which develops technology and equipment for research into genomics and proteomics; BIOMedi, which develops biotechnology applications in gene- and cell-based diagnostics and therapies; and AgriBIO, which concentrates on agricultural biotechnology. Through strategic alliances with other industry leaders, the Company aims to become a leader in creating innovative technologies for use in all parts of the world. Source: Takara Bio Inc. Contact: Corporate Communications Takara Bio Inc. E-mail: bio-ir@takara-bio.co.jp Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion